Shanghai Ovarian Cancer and Family Care Project
NCT06118307
Summary
Ovarian cancer is the most lethal gynaecological malignancy, but its incidence in the general population is low. Due to the lack of effective prevention and successful screening approaches, most cases are diagnosed at advanced stages, leading to poor prognosis. In order to address the research requirements pertaining to ovarian cancer, the Shanghai Ovarian Cancer and Family Care Project was established. This initiative offers hospital-based resources for investigating ovarian cancer and high-risk populations. The project comprises an on-going ovarian cancer cohort, a high-risk population cohort, and a healthy population cohort. By leveraging these comprehensive cohorts, the project provides a unique platform for in-depth studies on the detection, prevention, early diagnosis, treatment, and prognosis of ovarian cancer.
Eligibility
Participant meet the criteria for one of the following conditions: * Patients attending the oncology department require differential diagnosis of ovarian cancer. * Patients with known high-risk factors for ovarian cancer, such as history of ovarian cancer or BRCA-associated cancer, etc. * Patients attending the Physical Examination Center who have normal findings on physical examination and no symptoms. Exclusion Criteria: * Individuals with evidence of another active cancer. * Individuals who have prior bilateral oophorectomy. * Individuals who are unwilling or unable to sign the informed consent form.
Conditions2
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06118307